Department of Veterinary Biopathological Science, Laboratory of Biotechnology, Section of Physiology, University of Perugia, Perugia, Italy.
Domest Anim Endocrinol. 2010 Aug;39(2):116-30. doi: 10.1016/j.domaniend.2010.03.001. Epub 2010 Apr 10.
The dynamic expression for estrogen receptor subtype-1 (ESR1), interleukin-1beta (IL1B), and apoptosis-associated genes, as well as nitric oxide synthase activity, were examined in corpora lutea (CL) of rabbits after prostaglandin F(2alpha) (PGF(2alpha)) administration on either day 4 or day 9 of pseudopregnancy. By reverse transcriptase polymerase chain reaction, the steady-state level of ESR1 transcript was lower (P < 0.01) and that of anti-apoptotic B-cell CLL/lymphoma 2 (BCL2) -like 1 (BCL2L1) was greater in day 4 (P < 0.01) than in day 9 CL. Western blot analysis revealed that BCL2-associated X protein (BAX) abundance was greater in day 4 (P < 0.01) than in day 9 CL, whereas BCL2L1 protein was undetectable at both luteal stages. After PGF(2alpha), ESR1 transcript decreased (P < 0.01) in day 9 CL, whereas IL1B mRNA showed a transitory increase (P < 0.01) at both stages. The pro-apoptotic tumor protein p53 (TP53) gene had diminished (P < 0.01) on day 4 and on day 9 after a transitory increase (P < 0.01), whereas the BAX/BCL2L1 expression ratio increased (P < 0.01) in day 9 CL 24 h after treatment. Following PGF(2alpha), TP53 protein increased (P < 0.01) at both luteal stages, and BAX decreased (P < 0.01) in day 4 CL but increased (P < 0.01) 24 h later in day 9 CL; BCL2L1 became detectable 6 h later in day 4 CL. Nitric oxide synthase activity temporarily increased (P < 0.01) following PGF(2alpha). These findings suggest that PGF(2alpha) regulates luteolysis by ESR1 mRNA down-regulation and modulation of pro- and anti-apoptotic pathways in CL that have acquired a luteolytic capacity.
前列腺素 F2α(PGF2α)在假孕第 4 天或第 9 天给药后,检测了兔黄体(CL)中雌激素受体亚型 1(ESR1)、白细胞介素 1β(IL1B)和凋亡相关基因的动态表达以及一氧化氮合酶活性。通过逆转录聚合酶链反应,第 4 天(P <0.01)ESR1 转录本的水平较低,而抗凋亡 B 细胞 CLL/淋巴瘤 2(BCL2)样 1(BCL2L1)的水平较高。Western blot 分析显示,第 4 天(P <0.01)BAX 丰度大于第 9 天 CL,而 BCL2L1 蛋白在两个黄体阶段均不可检测。PGF2α 后,第 9 天 CL 中的 ESR1 转录本减少(P <0.01),而 IL1B mRNA 则在两个阶段均表现出短暂增加(P <0.01)。促凋亡肿瘤蛋白 p53(TP53)基因在第 4 天减少(P <0.01),在第 9 天短暂增加(P <0.01)后减少,而 BAX/BCL2L1 表达比在治疗后第 9 天 CL 增加(P <0.01)24 小时。PGF2α 后,TP53 蛋白在两个黄体阶段均增加(P <0.01),第 4 天 CL 中的 BAX 减少(P <0.01),但在第 9 天 CL 24 小时后增加(P <0.01),BCL2L1 在第 4 天 CL 中 6 小时后变得可检测。PGF2α 后一氧化氮合酶活性暂时增加(P <0.01)。这些发现表明,PGF2α 通过下调 ESR1 mRNA 并调节已获得黄体溶解能力的 CL 中的促凋亡和抗凋亡途径来调节黄体溶解。